Operational Queue
Monitor SLA-backed work items, pending approvals, and deterministic escalation rules.
Investigator View · TRL-0011
Investigator trial detail exposes startup, enrollment, and site execution context with deterministic metrics for portal planning. Regulated and operational boundaries remain labeled so users know which fields are informational versus workflow-driven. All portal actions are traceable through linked audit events and correlation IDs. Users can review study progression and align site readiness actions from a single governed page.
Type: Portal-onlyLast reviewed: 2026-02-19Owner: Medical AffairsStatus: Reviewed
Governed Actions
Submissions, exports, and AI runs are audit logged with correlation IDs and retention rules.
Portal Controls
Role constraints enforce ABAC-like behavior for content classes and workflow actions.
Page Focus
This child portal page emphasizes its dedicated operational detail content rather than section landing tiles.
LYA-210 durability study 11
Internal ID: TRL-0011
NCT-like: NCT90000010
Objective: Assess efficacy, safety, and patient-reported outcomes using a controlled synthetic protocol.
Endpoints: Primary endpoint is change from baseline at week 24 with key secondary safety measures.
Timeline: 2022-01-31 to 2026-01-31
Inclusion snapshot: protocol-defined adults with condition-specific disease activity and baseline laboratory eligibility.
Exclusion snapshot: recent conflicting therapies, unresolved safety findings, and protocol-prohibited concomitant conditions.
Site Locations
- Site 11 Medical Center | PI: Dr. Patel | Closed
- Site 171 University Hospital | PI: Dr. Patel | Closed
- Site 331 Medical Center | PI: Dr. Kim | Closed
- Site 491 Medical Center | PI: Dr. Harper | Closed
- Site 651 University Hospital | PI: Dr. Patel | Closed
- Site 811 University Hospital | PI: Dr. Patel | Closed